Stocks and Investing
Stocks and Investing
Thu, February 29, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Corinne Jenkins Maintained (TGTX) at Hold with Increased Target to $13 on, Feb 29th, 2024
Corinne Jenkins of Goldman Sachs, Maintained "TG Therapeutics, Inc." (TGTX) at Hold with Increased Target from $12 to $13 on, Feb 29th, 2024.
Corinne has made no other calls on TGTX in the last 4 months.
There are 4 other peers that have a rating on TGTX. Out of the 4 peers that are also analyzing TGTX, 0 agree with Corinne's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Corinne
- Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $45 on, Wednesday, February 28th, 2024
- Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $29 on, Monday, February 5th, 2024
- Eric Joseph of "JP Morgan" Maintained at Buy with Increased Target to $23 on, Wednesday, November 1st, 2023
- Matthew Andrews of "Jefferies" Maintained at Strong Buy on, Wednesday, November 1st, 2023
Contributing Sources